This systematic review looked at preclinical research involving various types of cancer. Scientists studied the impact of piperine on cancer cell lines in laboratory settings and in living animals. The goal was to understand how this compound interacts with cancer hallmarks like cell growth, inflammation, and metastasis.
The studies found that piperine inhibited the proliferation of cancer cell lines. It also appeared to improve the bioavailability of other drugs and reduce resistance to conventional chemotherapy agents. These effects were linked to the modulation of specific signaling pathways within the cells.
Despite these encouraging lab results, there are significant limitations. The compound has poor solubility and low bioavailability, which makes delivering it effectively difficult. Furthermore, there is a complete lack of clinical research in humans. Therefore, the therapeutic use of piperine for cancer is currently limited by these formulation issues and the absence of human trial data.
Readers should take from this that while the findings are promising, they require additional research to confirm piperine's potential as an effective anticancer treatment in real-world medical practice.